C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/06 (2006.01) A61K 31/4725 (2006.01) A61P 9/10 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2695973
Provided is a novel salt form of (R)-3-[2-(2- hydroxymethylpyrrolidin-1-yl)ethyl]-5-methyl-2H-isoquinolin-1- one. (R)-3-[2-(2-Hydroxymethylpyrrolidin-1-yl)ethyl]-5-methyl- 2H-isoquinolin-1-one monophosphate is a compound which is chemically stable, has high solubility, and shows less weight change due to humidity as compared to a free form and monohydrochloride dihydrate, and is superior as a bulk drug for pharmaceutical products.
L'invention porte sur une nouvelle forme de sel de la (R)-3-[2-(2-hydroxyméthylpyrrolidin-1-yl)éthyl]-5-méthyl-2H-isoquinolin-1-one. Le composé est le monophosphate de (R)-3-[2-(2-hydroxyméthylpyrrolidin-1-yl)éthyl]-5-méthyl-2H-isoquinolin-1-one. Par comparaison avec la forme libre et le monochlorhydrate dihydrate, ce monophosphate est chimiquement plus stable, présente une solubilité supérieure et présente une moindre variation de poids avec l'humidité. C'est un excellent composé destiné à être utilisé comme médicament brut pour des médicaments.
Fujio Masakazu
Ito Takanori
Satoh Hiroyuki
Takayanagi Hisao
Tanaka Toshihiko
Kirby Eades Gale Baker
Mitsubishi Tanabe Pharma Corporation
LandOfFree
Novel salt of isoquinoline compound and crystal thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel salt of isoquinoline compound and crystal thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel salt of isoquinoline compound and crystal thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1870358